JPH03255029A - Inhibitor of rise and drop in blood pressure and its production - Google Patents

Inhibitor of rise and drop in blood pressure and its production

Info

Publication number
JPH03255029A
JPH03255029A JP4940990A JP4940990A JPH03255029A JP H03255029 A JPH03255029 A JP H03255029A JP 4940990 A JP4940990 A JP 4940990A JP 4940990 A JP4940990 A JP 4940990A JP H03255029 A JPH03255029 A JP H03255029A
Authority
JP
Japan
Prior art keywords
water
blood pressure
hemicellulose
soluble hemicellulose
arabinose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP4940990A
Other languages
Japanese (ja)
Other versions
JP2804587B2 (en
Inventor
Toshiaki Kodama
俊明 児玉
Kiwamu Shiiba
究 椎葉
Hiroyoshi Hara
原 博嘉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nisshin Seifun Group Inc
Original Assignee
Nisshin Seifun Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nisshin Seifun Group Inc filed Critical Nisshin Seifun Group Inc
Priority to JP4940990A priority Critical patent/JP2804587B2/en
Publication of JPH03255029A publication Critical patent/JPH03255029A/en
Application granted granted Critical
Publication of JP2804587B2 publication Critical patent/JP2804587B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Abstract

PURPOSE:To obtain an inhibitor for rise and drop of blood pressure, showing effects with a small amount of administration, comprising a water-soluble hemicellulose having a molar ratio of xylose and arabinose in a specific range. CONSTITUTION:An inhibitor for rise and drop of blood pressure, comprising a water-soluble hemicellulose having a saccharide composition with a molar ratio of xylose and arabinose of 1:(0.95-1.2). The preparation is obtained by (i) partially hydrolyzing a water-soluble hemicellulose (preferably with an enzyme), treating the hydrolyzate with an ultrafilter having 8,000-50,000 fractionated molecular weight, separating and recovering a fraction having the above- mentioned saccharide composition, (ii) by dissolving a hemicellulose in a buffer solution having pH 7.5-8.5, passing through an anion exchange resin, absorbing, eluting using an aqueous solution of sodium chloride and recovering a fraction to elute at 0.1-0.3mol concentration and (iii) by adding 80% ethanol solution to a water-soluble hemicellulose and recovering a fraction having the above- mentioned composition from supernatant liquid from which the formed precipitate is separated and removed.

Description

【発明の詳細な説明】 [産業上の利用分野] 本発明は血圧降下および上昇抑制剤、ならびにその製造
方法に関する。
DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to an agent for lowering and suppressing blood pressure increase, and a method for producing the same.

[従来の技術] 近年、成人病の予防、コレステロールの低下および上昇
抑制作用、整腸作用、大腸ガンの予防等の点から食物繊
維(ダイエタリーファイバー)の有効性が再認識されて
おり、それに伴って食物繊維の積極的な摂取が種々試み
られるようになった。そして、そのような試みの例とし
ては、これまで米糠や小麦フスマ等からヘミセルロース
を抽出してこれを血清コレステロール、中性脂肪、肝臓
コレステロールの上昇抑制物質として利用することが提
案されている(特公昭62−6691号公報、特開昭6
3−216822号公報等)。
[Prior Art] In recent years, the effectiveness of dietary fiber has been re-recognized in terms of preventing adult diseases, lowering and suppressing cholesterol rise, regulating the intestines, and preventing colon cancer. As a result, various attempts have been made to actively intake dietary fiber. As an example of such an attempt, it has been proposed to extract hemicellulose from rice bran, wheat bran, etc. and use it as a substance that suppresses increases in serum cholesterol, neutral fat, and liver cholesterol (especially Publication No. 62-6691, Japanese Unexamined Patent Publication No. 62-6691
3-216822, etc.).

[発明の内容] 本発明者らもヘミセルロースの物性改良や有効利用につ
いて研究を続けてきた。ヘミセルロース(非セルロース
性多糖類)は、フスマ等のヘミセルロース含有原料から
ます殿粉、蛋白質、脂質、少糖類、無機質等を除き、残
部をアルカリで抽出処理することにより回収される。こ
のアルカリ抽出により得られたヘミセルロースは水溶性
ヘミセルロースと水不溶性または水難溶性ヘミセルロー
スとからなっており、これから水溶性ヘミセルロースを
分離回収する。水溶性ヘミセルロースのうちでもフスマ
由来の水溶性ヘミセルロースは、一般に、下記の表−1
に示す成分組成および糖組成を有している(表−1も含
めて本願明細書の%はすべて重量%を意味する)。
[Contents of the Invention] The present inventors have also continued research on improving the physical properties and effective utilization of hemicellulose. Hemicellulose (non-cellulosic polysaccharide) is recovered by removing starch, proteins, lipids, oligosaccharides, inorganic substances, etc. from hemicellulose-containing raw materials such as wheat bran, and extracting the remainder with alkali. The hemicellulose obtained by this alkaline extraction consists of water-soluble hemicellulose and water-insoluble or poorly water-soluble hemicellulose, from which the water-soluble hemicellulose is separated and recovered. Among water-soluble hemicelluloses, water-soluble hemicelluloses derived from wheat bran are generally listed in Table 1 below.
It has the component composition and sugar composition shown in (all % in this specification, including Table 1, means weight %).

[表−1] フスマ由来水溶性ヘミセルロースの成分含有量灰   
 分 蛋白質 全糖量 その他 約0.1〜0.5% 約4.8〜10,0% 約86,0〜93.6% 約1.4〜3.5% 合計 上記全糖量の内訳 キシロース アラビノース グルコース グルクロン酸 その他の糖 100.0 % 約45〜50% 約35〜40% 約2〜lO% 約3.5〜4.5% 約O〜5% 合   計 lOO% 上記表−1から明らかなように、フスマ由来水溶性ヘミ
セルロースでは、通常、キシロース:アラビノースのモ
ル比が1:約0.80〜0.89の糖組成を有し、キシ
ロースの方がアラビノースよりも含有量が多くなってい
る(なお、キシロースとアラビノースとは共に分子量1
50であり、重量%による対比がそのままモル比となる
)。
[Table 1] Component content of water-soluble hemicellulose derived from wheat bran
MinutesProtein Total SugarOther Approximately 0.1-0.5% Approximately 4.8-10,0% Approximately 86,0-93.6% Approximately 1.4-3.5% TotalSugar Breakdown of the Above Total Sugar ContentXylose Arabinose glucose glucuronic acid Other sugars 100.0% Approximately 45-50% Approximately 35-40% Approximately 2-10% Approximately 3.5-4.5% Approximately O-5% Total 100% It is clear from Table 1 above As shown, water-soluble hemicellulose derived from wheat bran usually has a sugar composition with a xylose:arabinose molar ratio of 1: about 0.80 to 0.89, with the content of xylose being higher than that of arabinose. (Note that both xylose and arabinose have a molecular weight of 1
50, and the comparison by weight % directly becomes the molar ratio).

本発明者らが研究をすすめた結果、上記水溶性ヘミセル
ロースは、キシロース:アラビノースのモル比が1+0
.95〜1.2の糖組成を有する区分と、キシロース:
アラビノースのモル比が1 : 0.40〜0.60の
糖組成を有する区分の2者の混合物からなっていること
を確認した。そして、本発明者らは上記2つの区分を分
離回収すべく更に研究を続けたところ、各区分の円滑な
分離回収法を見出すとともに、上記キシロース:アラビ
ノースのモル比がl:0.95〜1.2の糖組成を有す
る区分が血圧降下および上昇抑制作用を示すのに対して
、アラビノース含有量の少ない上記キシロース:アラビ
ノースのモル比がに0.40〜0.60の糖組成を有す
る区分は血圧降下および上昇抑制作用を示さないことを
も発見して本発明を完成したのである。
As a result of research conducted by the present inventors, the water-soluble hemicellulose has a xylose:arabinose molar ratio of 1+0.
.. Classification with sugar composition of 95-1.2 and xylose:
It was confirmed that the molar ratio of arabinose was 1: a mixture of two sugars having a sugar composition of 0.40 to 0.60. The present inventors continued their research to separate and recover the above two categories, and found a smooth separation and recovery method for each category, and found that the molar ratio of xylose:arabinose was 1:0.95 to 1. The category with a sugar composition of .2 exhibits a blood pressure lowering and increase suppressing effect, whereas the category with a sugar composition with a xylose:arabinose molar ratio of 0.40 to 0.60 has a low arabinose content. They also discovered that it does not exhibit the effect of lowering or suppressing blood pressure rise, and completed the present invention.

=4 したがって、本発明は、キシロース:アラビノースのモ
ル比がl:o、95〜1.2の糖組成を有する水溶性ヘ
ミセルロースからなる血圧降下および上昇抑制剤である
=4 Therefore, the present invention is a blood pressure lowering and increasing suppressant comprising a water-soluble hemicellulose having a sugar composition with a molar ratio of xylose:arabinose of l:o and a sugar composition of 95 to 1.2.

また、本発明は、該血圧降下および上昇抑制剤を製造す
るための下記の(1)〜(iii)の方法を包含する。
Further, the present invention includes the following methods (1) to (iii) for producing the blood pressure lowering and increasing suppressing agent.

(i)  水溶性ヘミセルロースを部分加水分解した後
、限外濾過膜で処理して、キシロース:アラビノースの
モル比がl:o、95〜1.2の糖組成を有する区分を
分離回収することを特徴とする血圧降下および上昇抑制
剤の製造方法、 (ii)  水溶性ヘミセルロースを緩衝液に溶解した
後、陰イオン交換樹脂に通して吸着させ、次いで塩化ナ
トリウム水溶液の濃度を0モルから0.4モルまで徐々
に上昇させた溶離液を通し、濃度0.1〜0.3モルの
溶離液で溶離するギシロース:アラビノースのモル比が
l:0.95〜1.2の糖組成を有する区分を回収する
ことを特徴とする血圧降下および上昇抑制剤の製造方法
、および (iiI)水溶性ヘミセルロースに60%エタノール溶
液を加え、そこで生成した沈澱物を分離除去した上澄液
からキシロース:アラビノースのモル比が1=0.95
〜1.2の糖組成を有する区分を回収することを特徴と
する血圧降下および上昇抑制剤の製造方法。
(i) After partially hydrolyzing water-soluble hemicellulose, it is treated with an ultrafiltration membrane to separate and recover a fraction having a xylose:arabinose molar ratio of l:o and a sugar composition of 95 to 1.2. Characteristic method for producing a blood pressure lowering and increasing suppressant: (ii) After dissolving water-soluble hemicellulose in a buffer solution, it is adsorbed by passing it through an anion exchange resin, and then the concentration of the sodium chloride aqueous solution is adjusted from 0 mol to 0.4 mol. A section having a sugar composition with a gylose:arabinose molar ratio of 1:0.95 to 1.2 is eluted with an eluent having a concentration of 0.1 to 0.3 molar. A method for producing a blood pressure lowering and increasing suppressant, and (iii) adding a 60% ethanol solution to water-soluble hemicellulose and separating and removing a precipitate formed therein. Ratio is 1=0.95
A method for producing a blood pressure lowering and increasing suppressant, which comprises recovering a fraction having a sugar composition of ~1.2.

上記(i)〜(in)の方法で出発物質として使用する
水溶性ヘミセルロースは、小麦、大麦、カラス麦、ライ
麦、エン麦等の麦類のフスマやその他のヘミセルロース
含有原料をアルカリで抽出処理し、そこで得られたヘミ
セルロースから水溶性の区分を分離回収することにより
製造される。水溶性ヘミセルロースであればいずれのも
のでもよくそれに限定されない。
The water-soluble hemicellulose used as a starting material in methods (i) to (in) above is obtained by extracting bran from wheat, barley, oats, rye, oats, and other hemicellulose-containing raw materials with an alkali. It is produced by separating and collecting the water-soluble fraction from the hemicellulose obtained there. Any water-soluble hemicellulose may be used without limitation.

そして、上記(i)の方法によって本発明の血圧降下お
よび上昇抑制剤を製造するにあたっては、まず上記した
水溶性ヘミセルロースを部分加水分解する。かかる部分
加水分解処理によって、キシロース:アラビノースのモ
ル比がに0.4〜0.6の糖組成を有する区分(以下、
3区分という)が選択的に加水分解され、キシロース:
アラビノースのモル比が1+0.95〜1.2の糖組成
を有する区分(以下、へ区分という)は殆ど加水分解さ
れずに残る。部分加水分解は水溶性ヘミセルロースを酵
素、酸、アルカリ等により行うが、酵素による処理が加
水分解の過不足等を伴わず、温和な条件下で目的とする
物質を効率良く製造し得るので好ましい。そのための酵
素としては、ヘミセルラーゼ、セルラーゼ等の植物繊維
組織崩壊酵素が使用できる。その際に酵素は遊離の状態
で使用しても担体に固定化して使用してもよい。また部
分加水分解処理は連続法で行ってもバッチ法で行っても
よい。水溶性ヘミセルロースの種類、酵素を遊離の状態
で使用するかまたは固定化して使用するか、連続法で行
うかまたはバッチ法で行うか等に応じて酵素の種類、そ
の使用量、部分加水分解時の温度、圧力、pH1時間等
を選択して行うとよい。
In producing the agent for lowering and suppressing blood pressure increase of the present invention by the method (i) above, first, the water-soluble hemicellulose described above is partially hydrolyzed. Through this partial hydrolysis treatment, a classification (hereinafter referred to as
3 categories) are selectively hydrolyzed to produce xylose:
The segment having a sugar composition with an arabinose molar ratio of 1+0.95 to 1.2 (hereinafter referred to as segment) remains almost unhydrolyzed. Partial hydrolysis of water-soluble hemicellulose is carried out using enzymes, acids, alkalis, etc., and treatment with enzymes is preferable because it does not involve excessive or insufficient hydrolysis, and the desired substance can be efficiently produced under mild conditions. As the enzyme for this purpose, plant fiber tissue disintegrating enzymes such as hemicellulase and cellulase can be used. At this time, the enzyme may be used in a free state or immobilized on a carrier. Further, the partial hydrolysis treatment may be carried out in a continuous method or in a batch method. Depending on the type of water-soluble hemicellulose, whether the enzyme is used in a free or immobilized state, whether it is carried out in a continuous method or a batch method, etc., the type of enzyme, its usage amount, and the time of partial hydrolysis are determined. It is preferable to select the temperature, pressure, pH, etc. for 1 hour.

− 例えば、小麦フスマ由来水溶性ヘミセルロースをヘミセ
ルラーゼ(ヤクルト社製゛オノズカR3′″)を使用し
て部分加水分解する場合は、該ヘミセルロースの約1〜
10%水溶液(pH約3.5〜7.0)を形成し、この
水溶液に約2〜1001000pp/v)の1′オノズ
カRS ”を加えて約40−60°Cの温度で約5分〜
1時間加水分解するとよい。この加水分解反応において
、該ヘミセルロース水溶液の粘度が当初急激に低下しそ
の後は徐々に低下してゆくが、急激な粘度低下が終了し
た時点で加水分解反応を停止させるのがよい。次に、部
分加水分解された水溶性ヘミセルロース水溶液を限外濾
過膜で処理して、上記A区分を分離回収する。ここで使
用する限外濾過膜としては、従来から知られているポリ
スルホン、アクリロニトリル共重合体、芳香族ポリアミ
ド、ポリフッ化ビニリデン、ポリエーテルスルホン樹脂
、ポリイミド樹脂等のポリマーかもなる膜のいずれもが
使用できる。また、形状の違いにより管状膜、平膜、ス
パイラルモジュール、中空モ− ジュール等の形状のものが知られているが、それらの中
でも10〜15mmの内径を有するポリスルホン製の管
状膜が目詰まりがなく短時間で多量の水溶液を精製処理
できるので好ましい。ポリオレフィン系の限外濾過膜は
目的物の吸着を生じ易く好ましくない。膜の分画性能と
しては分画分子量で表した場合に約8,000〜50,
000のものが好ましい。この限外濾過膜による目的物
の分離回収に際しては、部分加水分解された水溶性ヘミ
セルロースの水溶液を管状膜の内側に通し、て濾過を行
い、膜の外側に目的物以外の物質を含む透過液を排出す
る処理を行う。その際に膜を透過する溶液量と同量の水
を管状膜の内側に常に供給して膜処理液量を一定に保ち
ながら処理を行うと効率よく目的物を得ることができる
。その場合に、通常、管状膜内部の水溶液に約5〜10
kg−f/cm”圧力をかけて処理を行う。また、処理
時に水溶液の温度を約40〜60℃に維持しておくのが
よい。
- For example, when partially hydrolyzing water-soluble hemicellulose derived from wheat bran using hemicellulase (Onozuka R3''' manufactured by Yakult), approximately 1 to 100% of the hemicellulose
Form a 10% aqueous solution (pH about 3.5 to 7.0), add about 2 to 1001000 pp/v of 1' Onozuka RS'' to this aqueous solution, and heat at a temperature of about 40-60°C for about 5 minutes.
It is recommended to hydrolyze for 1 hour. In this hydrolysis reaction, the viscosity of the hemicellulose aqueous solution initially decreases rapidly and then gradually decreases, but it is preferable to stop the hydrolysis reaction when the rapid viscosity decrease ends. Next, the partially hydrolyzed water-soluble hemicellulose aqueous solution is treated with an ultrafiltration membrane to separate and recover the above-mentioned Class A. As the ultrafiltration membrane used here, any of the conventionally known membranes made of polymers such as polysulfone, acrylonitrile copolymer, aromatic polyamide, polyvinylidene fluoride, polyethersulfone resin, and polyimide resin can be used. can. In addition, there are various shapes known, such as tubular membranes, flat membranes, spiral modules, and hollow modules, among which polysulfone tubular membranes with an inner diameter of 10 to 15 mm are used to prevent clogging. This is preferable because a large amount of aqueous solution can be purified in a short period of time. Polyolefin-based ultrafiltration membranes are undesirable because they tend to adsorb target substances. The fractionation performance of the membrane is approximately 8,000 to 50 when expressed in molecular weight cutoff.
000 is preferred. When separating and recovering the target product using this ultrafiltration membrane, an aqueous solution of partially hydrolyzed water-soluble hemicellulose is passed through the inside of the tubular membrane and filtered, and a permeate containing substances other than the target product appears on the outside of the membrane. Process to discharge. At this time, the target product can be efficiently obtained by constantly supplying the same amount of water to the inside of the tubular membrane as the amount of solution passing through the membrane to keep the amount of membrane treatment liquid constant. In that case, the aqueous solution inside the tubular membrane usually contains about 5 to 10
The treatment is carried out by applying a pressure of 1.5 kg-f/cm. It is also preferable to maintain the temperature of the aqueous solution at about 40 to 60° C. during the treatment.

かかる方法で限外濾過膜処理すると、A区分が得られる
When treated with an ultrafiltration membrane in this manner, Class A is obtained.

また、上記(■)の方法による場合は、pH約7.5〜
8.5の緩衝液20m12当たり水溶性ヘミセルロース
約150〜250mgを溶解した溶液を、陰イオン交換
樹脂に通して吸着させ、次いで前記緩衝液を0.5〜1
.5mQ/分で5〜6時間通液し、次いで塩化ナトリウ
ム水溶液からなる溶離液の塩化ナトリウム濃度を0モル
から約0.4モルまで徐々に上昇させながら0.5〜1
.5mQ/分で通液してイオン交換樹脂吸着物を溶離さ
せると、塩化すトリウム濃度が0.1〜0.3モルの溶
離液から得られた溶離区分中に大区分が選択的に溶離さ
れてくるのでそれを回収し、脱塩処理する。かかるイオ
ン交換樹脂による場合には、上記の緩衝液としては、ト
リス−塩酸緩衝液、リン酸緩衝液等が、また陰イオン交
換樹脂としてはDEAEにセルロースの誘導体を結合さ
せたもの等が使用でき、そのうちでも特にDEAE−3
epharose (スウェーデン、ファルマシア社製
)が好ましい。
In addition, when using the method (■) above, the pH is about 7.5 to
A solution of about 150-250 mg of water-soluble hemicellulose per 20 ml of 8.5 m buffer is adsorbed through an anion exchange resin, and then the buffer is absorbed at 0.5-1 m
.. The solution was passed at a rate of 5 mQ/min for 5 to 6 hours, and then the sodium chloride concentration of the eluent consisting of an aqueous sodium chloride solution was gradually increased from 0 mol to about 0.4 mol, while increasing the sodium chloride concentration from 0.5 to 1.
.. When the ion-exchange resin adsorbate is eluted by passing at a rate of 5 mQ/min, a large fraction is selectively eluted in the eluted fraction obtained from the eluent with a thorium chloride concentration of 0.1 to 0.3 mol. It is collected and desalted. In the case of using such an ion exchange resin, Tris-HCl buffer, phosphate buffer, etc. can be used as the above-mentioned buffer solution, and as an anion exchange resin, DEAE combined with a cellulose derivative can be used. , especially DEAE-3
Epharose (manufactured by Pharmacia, Sweden) is preferred.

更に、上記(市)の方法による場合は、水lQ当たり水
溶性ヘミセルロース約lO〜100gを溶解させた溶液
にエタノールを加え、そのエタノール溶液を60%に調
整すると8区分が沈澱するので、60%エタノール溶液
中に溶解している大区分を上澄み液として回収し、60
%エタノール溶媒を任意の方法で除去して目的物を回収
することができる。
Furthermore, in the case of the above method (Ichi), ethanol is added to a solution in which about 10 to 100 g of water-soluble hemicellulose is dissolved per 1Q of water, and when the ethanol solution is adjusted to 60%, 8 sections will precipitate, so 60% The large fraction dissolved in the ethanol solution was collected as a supernatant liquid, and
% ethanol solvent can be removed by any method to recover the target product.

出発原料である水溶性ヘミセルロース、酵素による部分
加水分解物並びに本発明の血圧降下および上昇抑制剤の
成分組成、糖組成および5%水溶液のは、はぼ以下の表
−2のようになっている。
The component composition, sugar composition, and 5% aqueous solution of the water-soluble hemicellulose as the starting material, the enzymatic partial hydrolyzate, and the antihypertensive and antihypertensive agent of the present invention are as shown in Table 2 below. .

11− 2 灰   分(%) 蛋白質(%) 全糖量(%) その他(%) 合  計 (%) 全糖量り内訳 キシロース (%) アラビノース(%) グルコース (%) グルクロン酸(%) その他の糖 (%) 合計(%) 5%水溶液粘度(cP) [表−2] 0.1〜0.5 4.8〜10,0 86.0〜93.6 1.4〜3.5 ioo、。11- 2 Ash Minute (%) protein(%) Total sugar amount (%) others(%) total (%) Total sugar measurement breakdown Xylose (%) Arabinose (%) Glucose (%) Glucuronic acid (%) Other sugars (%) total(%) 5% aqueous solution viscosity (cP) [Table-2] 0.1-0.5 4.8~10.0 86.0-93.6 1.4-3.5 ioo,.

45〜50 35〜40 2〜10 3.5〜4.5 0〜5 100.0 +68 0.1〜0.5 4.5〜10.0 85.0〜95.0 1.2〜3.5 100.0 45〜50 35〜40 2〜10 3.5〜4.5 0〜5 100.0 4 0.1−0.5 4.5〜10.0 85、O〜95.0 1.2〜3.5 100.0 40〜45 40〜45 0〜5 4.5〜5.5 0〜5 1.00.0 0 ここで、上記表−2中の全糖量は下記のようにして求め
た。糖分中の各構成成分(キシロース、アラビノース、
グルコース等)の含有量はヘミセルロースをTi1O,
BHATTI等の方法[Biochim、  Biop
hys、  Acta、  222(1970)339
−347]により加水分解した後メチル化し、これをガ
スクロマトグラフィーを使用して分析することにより求
めた。表−2中の値は全て乾物として換算した値である
45-50 35-40 2-10 3.5-4.5 0-5 100.0 +68 0.1-0.5 4.5-10.0 85.0-95.0 1.2-3. 5 100.0 45-50 35-40 2-10 3.5-4.5 0-5 100.0 4 0.1-0.5 4.5-10.0 85, O-95.0 1. 2-3.5 100.0 40-45 40-45 0-5 4.5-5.5 0-5 1.00.0 0 Here, the total sugar amount in Table 2 above is calculated as follows. I asked. Each component in sugar (xylose, arabinose,
The content of hemicellulose (glucose, etc.) is Ti1O,
The method of BHATTI et al. [Biochim, Biop
hys, Acta, 222 (1970) 339
-347], followed by methylation and analysis using gas chromatography. All values in Table 2 are values calculated as dry matter.

[全糖量の測定法] 糖類を含有する水溶液を蒸留水で100倍に希釈する。[Method for measuring total sugar content] The aqueous solution containing sugars is diluted 100 times with distilled water.

次にこの希釈された水溶液0.5m(2に5%フェノー
ル水溶液0.5m4を添加して撹拌した後濃硫酸3mO
,を加えて更に撹拌した。そのまま20分間放置して空
冷した後、波長490nmの吸光度を測定する。測定値
をキシロースを基質とした漂準曲線に照合して全糖量を
求めた。
Next, 0.5 m4 of a 5% phenol aqueous solution was added to 0.5 m4 of this diluted aqueous solution (2), and after stirring, 3 mO concentrated sulfuric acid was added.
, and further stirred. After leaving it as it is for 20 minutes and cooling it in the air, absorbance at a wavelength of 490 nm is measured. The total sugar content was determined by comparing the measured values with a drift curve using xylose as a substrate.

本発明の血圧降下および上昇抑制剤は、水溶性の白色粉
末であって、これを人間および種々の動物(例えば、犬
、ネコ等のペット類)に少量3 投与することによって、高血圧症の人間や動物の血圧を
降下させることができ更に血圧の上昇を抑制することが
できる。
The antihypertensive and antihypertensive agent of the present invention is a water-soluble white powder, and by administering it to humans and various animals (for example, pets such as dogs and cats) in small amounts, it can be used to treat hypertensive humans. It is possible to lower the blood pressure of animals and animals, and furthermore, it is possible to suppress the increase in blood pressure.

また、本発明の血圧降下および上昇抑制剤は、血圧降下
や血圧上昇抑制に関与することが知られているカリウム
を含有してもよく、カリウムの併用によって血圧降下お
よび血圧上昇抑制効果が一層増進される。この場合のカ
リウムは、塩化カリウム、炭酸カリウム、リン酸カリウ
ム等の無機カリウム塩または有機カリウム塩の形で使用
するのがよい。
Furthermore, the agent for lowering and suppressing blood pressure increase of the present invention may contain potassium, which is known to be involved in lowering blood pressure and suppressing blood pressure increase, and the combined use of potassium further enhances the effect of lowering blood pressure and suppressing blood pressure increase. be done. Potassium in this case is preferably used in the form of an inorganic potassium salt such as potassium chloride, potassium carbonate, potassium phosphate, or an organic potassium salt.

本発明の血圧降下および上昇抑制剤の好適な投与量は、
投与される人間や動物の年令、体重、性別、症状、動物
の種類等の種々の条件によって当然異なるが、例えば、
人間であれば体重1kg当たり1日に約0.01〜0.
5gの割合で、また動物の場合、体重1kg当たり1日
に約0.1〜10gの割合で投与することができる。
The preferred dosage of the antihypertensive and antihypertensive agent of the present invention is as follows:
Although it naturally varies depending on various conditions such as the age, weight, sex, symptoms, and type of animal of the human or animal to be administered, for example,
For humans, it is approximately 0.01 to 0.0.0% per kg of body weight per day.
It can be administered at a rate of 5 g, or in animals at a rate of about 0.1 to 10 g per kg body weight per day.

そして、本発明の血圧降下および上昇抑制剤は、経口投
与によって投与する。更に、本発明の血圧降下剤等は、
単独で投与しても、また製薬工業において通常使用され
ている固体担体や液状担体と一緒に投与してもよく、或
は他の薬剤と混合して、または組合わせて使用すること
ができる。その投与形態は、錠剤、丸剤、顆粒剤、カプ
セル、散剤、水溶液等の任意の形態で使用可能である。
The agent for lowering and suppressing blood pressure increase of the present invention is administered orally. Furthermore, the antihypertensive agent of the present invention, etc.
They may be administered alone, together with solid or liquid carriers commonly used in the pharmaceutical industry, or mixed with or in combination with other agents. The dosage form can be any form such as tablets, pills, granules, capsules, powders, and aqueous solutions.

更に、本発明の血圧降下および上昇抑制剤は、食品や飼
料中に添加して、またはそれらと−緒に投与することが
できる。
Furthermore, the agent for lowering and suppressing blood pressure increase of the present invention can be added to or administered together with foods and feeds.

以下に、本発明を例を挙げて具体的に説明するが本発明
はそれによって限定されない。
The present invention will be specifically explained below by giving examples, but the present invention is not limited thereto.

参  考  例 [小麦フスマ由来水溶性ヘミセルロースの調製]精選小
麦フスマ2kgを50℃の温水20Qに分散さぜ5分間
撹拌する。その後遠心濾過機(田辺鉄工断裂)で濾過し
て固形分を回収し、得られた固形分3kgを70℃、0
.2N水酸化ナトリウム水溶液2012に入れ90分間
撹拌する。放冷後に0.8N塩酸水溶液5aを撹拌下に
徐々に加えて中和5− する。中和溶液を5,0OOGで10分間遠心分離する
。その上澄み液を分取し、全糖量が5 mg/ mQに
なるように水で希釈し、液温50°Cに保温する。
Reference Example [Preparation of water-soluble hemicellulose derived from wheat bran] Disperse 2 kg of selected wheat bran in 20Q of warm water at 50°C and stir for 5 minutes. After that, the solid content was collected by filtration using a centrifugal filter (Tanabe Iron Works), and 3 kg of the obtained solid content was heated at 70°C and
.. Add to 2N aqueous sodium hydroxide solution 2012 and stir for 90 minutes. After cooling, 0.8N hydrochloric acid aqueous solution 5a is gradually added under stirring for neutralization. Centrifuge the neutralized solution at 5,0 OOG for 10 minutes. The supernatant liquid is separated, diluted with water to a total sugar content of 5 mg/mQ, and kept at a temperature of 50°C.

全溶液を管状限外濾過膜(日東電工製: NTU352
0PI8型、膜面積0−76 m”、内径1.1.5m
m)の管内を通し、圧力8kg/cm”、流速13 Q
 / m i nの条件下で3時間処理する。この時、
膜透過溶液と同量の水を常に管内に補給し膜処理液量を
一定とする。3時間抜水の供給を止め、前記と同様の条
件で濃縮を開始しフラックスの低下を考慮することなく
濃縮を行い、水溶液の糖濃度が約1゜n+g/mQにな
るまで約1.5時間行う。処理液をオルガノ社製陽イオ
ン交換樹脂IR−120E 500ccに1時間当たり
イオン交樹脂換容量の10倍の流速で溶出し、次いで同
社製の陰イオン交換樹脂IRA−93に同流速で流す。
The entire solution was filtered through a tubular ultrafiltration membrane (manufactured by Nitto Denko: NTU352).
0PI8 type, membrane area 0-76 m”, inner diameter 1.1.5 m
m), pressure 8 kg/cm", flow rate 13 Q
/min for 3 hours. At this time,
The same amount of water as the membrane permeation solution is always replenished into the tube to keep the amount of membrane treatment liquid constant. Stop the supply of drained water for 3 hours, start concentration under the same conditions as above, concentrate without considering the decrease in flux, and continue for about 1.5 hours until the sugar concentration of the aqueous solution reaches about 1゜n+g/mQ. conduct. The treated solution is eluted into a 500 cc cation exchange resin IR-120E manufactured by Organo Co., Ltd. at a flow rate of 10 times the exchange capacity of the ion exchange resin per hour, and then passed through an anion exchange resin IRA-93 manufactured by the same company at the same flow rate.

イオン交換処理後、得られた水溶液を真空凍結乾燥しく
温度30°C1真空度Q、l Torr以下)、白色の
ヘミセルロース粉末(イ) 150gを得た(精選小麦
フスマに割する回収率=7.5%)。得られたヘミセル
ロース粉6 末(イ)は25°Cの水に完全に溶解した。
After the ion exchange treatment, the resulting aqueous solution was vacuum freeze-dried at a temperature of 30° C., vacuum level Q, and 1 Torr or less) to obtain 150 g of white hemicellulose powder (a) (recovery rate divided into selected wheat bran = 7. 5%). The obtained hemicellulose powder 6 powder (a) was completely dissolved in water at 25°C.

実施例 1 」二足の参考例で調製されたフスマ由来水溶性ヘミセル
ロース粉末(イ) 150gを酢酸塩緩衝水溶液(酢酸
塩含有量50ミリモル、pH5,5) 15ffl=溶
解して1%水溶液を調製した。
Example 1 A 1% aqueous solution was prepared by dissolving 150 g of water-soluble hemicellulose powder derived from wheat bran (A) prepared in the two reference examples in 15 ffl of an acetate buffer aqueous solution (acetate content 50 mmol, pH 5.5). did.

この液を予め40°C′tl″lO分間加温した後、ヘ
ミセルラーゼ(ヤクルト社製゛′オノズヵR3” )を
75μg添加し、同温度に保って部分加水分解を20分
間行わ七た。その後、液を9000で1o分間加熱して
酵素を失活させた。この液の一部(1,0m12)を採
取し、25°C11ooミリトールで凍結真空乾燥して
ヘミセルロース粉末(ロ)0.47gt−得り。
After preheating this solution for 40° C. for 10 minutes, 75 μg of hemicellulase (“Onozuka R3” manufactured by Yakult) was added, and partial hydrolysis was carried out for 20 minutes while maintaining the same temperature. Thereafter, the solution was heated at 9,000° C. for 10 minutes to inactivate the enzyme. A portion (1.0 ml) of this liquid was collected and freeze-vacuum dried at 25° C. at 110 mTorr to obtain 0.47 gt of hemicellulose powder (b).

また、上記部分加水分解液の残部の温度を50℃に保ち
ながら管状限外濾過膜(NTU3520−PI3型:日
東電工社製:膜面積0.76m’、内径11.5mm)
の管内を通し圧力8kg−f/cm2、流速13 (1
/ m i nの条件下で処理した。この時、膜透過溶
液と同量の水を常に管内に補給し膜処理液量を一定とし
た。3時間後、給水を停止して前記と同様の条件で濃縮
を開始しフラックスの低下を考慮することなく水溶液の
糖濃度が約25mg/m4になるまで濃縮を行った。得
られた濃縮液を25°0.100ミリトールで凍結真空
乾燥して白色のヘミセルロース粉末(ハ)102gを得
た。
In addition, while maintaining the temperature of the remainder of the above partial hydrolysis solution at 50°C, a tubular ultrafiltration membrane (NTU3520-PI3 type: manufactured by Nitto Denko Corporation: membrane area 0.76 m', inner diameter 11.5 mm) was added.
through the pipe at a pressure of 8 kg-f/cm2 and a flow rate of 13 (1
/ min conditions. At this time, the same amount of water as the membrane permeation solution was constantly replenished into the tube to keep the amount of membrane treatment liquid constant. After 3 hours, the water supply was stopped and concentration was started under the same conditions as above, and concentration was carried out until the sugar concentration of the aqueous solution reached about 25 mg/m4 without considering the decrease in flux. The obtained concentrate was freeze-dried under vacuum at 25° and 0.100 mTorr to obtain 102 g of white hemicellulose powder (c).

実施例 2 上記参考例で調製したフスマ由来水溶性ヘミセルロース
(イ)150gを水2Qに溶解した溶液にエタノールを
加えて、そのエタノール濃度を60%に調整し、そのま
ま約20分間撹拌後静置した。
Example 2 Ethanol was added to a solution in which 150 g of the water-soluble hemicellulose derived from wheat bran (A) prepared in the above reference example was dissolved in 2Q of water to adjust the ethanol concentration to 60%, and the solution was stirred for about 20 minutes and then allowed to stand still. .

沈澱物を60%エタノールで洗浄し、凍結真空乾燥して
白色生成物(ニ)60gを得た。
The precipitate was washed with 60% ethanol and freeze-dried in vacuum to obtain 60 g of a white product (d).

また、濾液(上澄液)をエバポレーターによりエタノー
ル成分を蒸発させてから、25℃、100ミリトールで
凍結真空乾燥することによって白色生成物(ホ)90g
を得た。
In addition, 90 g of a white product (e) was obtained by evaporating the ethanol component of the filtrate (supernatant liquid) using an evaporator and then freeze-vacuum drying it at 25°C and 100 mTorr.
I got it.

実施例 3 上記参考例で調製したフスマ由来水溶性ヘミセルロース
(イ)200mgを20ミリモルのトリス−塩酸緩衝液
(pH8,5) 20mΩに溶解し、この液を陰イオン
交換樹脂DEAE−5epharose CL−6B(
ファルマシア社製)150mQを充填したカラムに通し
て吸着させ、次いで同緩衝液を0.7mQ1分の流速で
5時間通液して非吸着物を洗い流した。次に、塩化ナト
リウム濃度が0から0゜4モルに徐々に増加する溶離液
をカラムに0.7mQ1分の流速で通し、濃度0.1〜
0.3モルの溶離液から得られた溶離区分を得た。前記
非吸着物を含有する液と該吸着溶離区分を含有する液の
各々を乾燥したところ、40+60の重量割合で白色の
ヘミセルロース粉末(非吸着物)(へ)および白色のヘ
ミセルロース粉末(吸着物)(ト)の各々を得た。
Example 3 200 mg of water-soluble hemicellulose derived from wheat bran (A) prepared in the above reference example was dissolved in 20 mmol of Tris-HCl buffer (pH 8,5) 20 mΩ, and this solution was mixed with anion exchange resin DEAE-5epharose CL-6B. (
The mixture was passed through a column packed with 150 mQ (manufactured by Pharmacia) to adsorb it, and then the same buffer was passed through it at a flow rate of 0.7 mQ 1 minute for 5 hours to wash away non-adsorbed substances. Next, an eluent with a sodium chloride concentration gradually increasing from 0 to 0.4 mol was passed through the column at a flow rate of 0.7 mQ1 min.
An elution fraction obtained from 0.3 mol of eluent was obtained. When the liquid containing the non-adsorbed matter and the liquid containing the adsorption/elution section were each dried, white hemicellulose powder (non-adsorbed material) and white hemicellulose powder (adsorbed material) were obtained at a weight ratio of 40+60. (G) were obtained.

上記参考例で得た水溶性ヘミセルロース(イ)、実施例
1の加水分解ヘミセルロース(ロ)および限外濾過膜処
理ヘミセルロース(ハ)、実施例2で得た沈澱ヘミセル
ロース(ニ)および上澄みヘミセルロース(ホ)、並び
に実施例3のヘミセル1’−ス(非吸着物)(へ)およ
びヘミセルロース(吸着物)(ト)中の各成分の含有量
は次の表−319− 2〇− に示すとおりであった。
The water-soluble hemicellulose obtained in the above reference example (a), the hydrolyzed hemicellulose of Example 1 (b) and the ultrafiltration membrane-treated hemicellulose (c), the precipitated hemicellulose obtained in Example 2 (d) and the supernatant hemicellulose (ho). ), and the content of each component in the hemicellulose (non-adsorbed material) (g) and hemicellulose (adsorbed material) (g) of Example 3 are as shown in the following table -319-20- there were.

1表−3] lf    ロ   ハ   ニ   ホ   ヘ  
 ト蛋白質(%)  5.3 4.7 5.0 2.5
 5.4 0.8 4.8糖   類(%’)  91
.0  B9.7 91.8 93.6 90.4 9
6.4 92.4実施例 4 下記の表−4に示した組成からなる試験食■〜■を準備
した。
Table 1-3] lf lo ha ni ho he
Protein (%) 5.3 4.7 5.0 2.5
5.4 0.8 4.8 Sugars (%') 91
.. 0 B9.7 91.8 93.6 90.4 9
6.4 92.4 Example 4 Test foods 1 to 2 having the compositions shown in Table 4 below were prepared.

[表 j カゼイン L−メヂオニン ミネラルミックス ビタミンミックス シ    糖 ラ  −  ド 食   塩 参考例の水溶性ヘミセル ロース(イ) 3.8 実施例1の限外濾過膜処 環ヘミセルロース(ハ) 3.7 なお、上記試験食■〜■では、試験食中におけるキシロ
ースとアラビノースの総合有量が3%になるように、参
考例の水溶性へミセルロース(イ)、実施例1の限外濾
過膜処理ヘミセルロース(ハ)および実施例2の沈澱ヘ
ミセルロース(ニ)の各々を配合している。
[Table J Casein L-medionine Mineral Mix Vitamin Mix Sugar Lad Salt Reference Example Water Soluble Hemicellulose (A) 3.8 Ultrafiltration Membrane Treated Hemicellulose (C) of Example 1 3.7 , In the above test foods ■ to ■, the water-soluble hemicellulose (A) of the reference example and the ultrafiltration membrane-treated hemicellulose of Example 1 were used so that the total amount of xylose and arabinose in the test food was 3%. (c) and the precipitated hemicellulose (d) of Example 2 are each blended.

次いで、高血圧自然発症ラット(雄、9週令、平均体重
280g/匹)を各区6匹ずつ4区用意しIこ 。
Next, four groups of spontaneously hypertensive rats (male, 9 weeks old, average weight 280 g/animal), 6 rats in each group, were prepared.

各区のラットに対して、上記の試験食1〜■の各々を2
週間自由に摂取させた。
Two doses of each of the test foods 1 to ■ above were given to the rats in each group.
They were given free access for a week.

各区のラットの当初、1週間後および2週間後の血圧を
測定したところ下記の表−5に示すとおりであった。
The blood pressure of the rats in each group was measured initially, one week later, and two weeks later, and the results were as shown in Table 5 below.

[表−5] 血  圧(mm)Ig) 当  初 1週間後 2週間後 141±7.5 140±8.5 140±9.6 1
41±6.6153±4.0 147±4.6 1.4
6±19.2 152±4.3170±7.6 160
±5.8* 158±5.3*  167±6.0*印
は工と比べて危険率5%で有意差あり上記衣−5の結果
から、実施例2の沈澱生成物(ニ)を含有する試験食を
給与した■区のラットでは血圧の上昇がほとんど抑制さ
れていないのに対して、参考例の水溶性ヘミセルロース
(イ)および実施例1の限外濾過膜処理ヘミセルロース
(ハ)を含有している■区および■区のラットでは血圧
の上昇が抑制されており、特に■区では血圧の上昇抑制
が大きいことがわかる。
[Table-5] Blood pressure (mm) Ig) Initially 1 week after 2 weeks 141±7.5 140±8.5 140±9.6 1
41±6.6153±4.0 147±4.6 1.4
6±19.2 152±4.3170±7.6 160
±5.8 * 158 ± 5.3 * 167 ± 6.0 The increase in blood pressure was hardly suppressed in the rats in group ■ that were fed the test food containing the water-soluble hemicellulose (A) of the reference example and the ultrafiltration membrane-treated hemicellulose (C) of Example 1. It can be seen that the increase in blood pressure was suppressed in the rats in the ■ and ■ groups containing the drug, and the suppression of the increase in blood pressure was particularly large in the ■ group.

そして、このことから、A区分からなるヘミセルロース
が血圧の上昇抑制に有効であることがわかる。また、■
区で用いた水溶性ヘミセルロース(イ)は、へ区分と8
区分の両方を含み、そこに含まれるへ区分が血圧上昇抑
制剤として働いているものと考えられる。
From this, it can be seen that hemicellulose consisting of category A is effective in suppressing an increase in blood pressure. Also, ■
The water-soluble hemicellulose (A) used in Section 8 is
It is thought that the phytochemical contains both of the two categories, and that the subdivision contained therein acts as an antihypertensive agent.

[発明の効果〕 本発明の血圧降下および上昇抑制剤は、少量の投与で血
圧降下作用および血圧上昇抑制作用を示す。
[Effects of the Invention] The agent for lowering and suppressing blood pressure increase of the present invention exhibits a blood pressure lowering effect and a blood pressure increase suppressing effect when administered in a small amount.

また、本発明の製造方法によるときは、簡単な操作で純
度の高い血圧降下および上昇抑制剤23 4− を円滑に得ることができる。
Moreover, when using the production method of the present invention, highly pure blood pressure lowering and increasing suppressant 23 4- can be smoothly obtained with simple operations.

Claims (1)

【特許請求の範囲】 1)キシロース:アラビノースのモル比が1:0.95
〜1.2の糖組成を有する水溶性ヘミセルロースからな
る血圧降下および上昇抑制剤。 2)水溶性ヘミセルロースを部分加水分解した後、限外
濾過膜で処理して、キシロース:アラビノースのモル比
が1:0.95〜1.2の糖組成を有する区分を分離回
収することを特徴とする請求項1記載の血圧降下および
上昇抑制剤の製造方法。 3)水溶性ヘミセルロースを緩衝液に溶解した後、陰イ
オン交換樹脂に通して吸着させ、次いで塩化ナトリウム
の濃度を0モルから0.4モルにまで徐々に上昇させた
溶離液を通し、濃度0.1〜0.3モルの溶離液で溶離
するキシロース:アラビノースのモル比が1:0.95
〜1.2の糖組成を有する区分を回収することを特徴と
する請求項1記載の血圧降下および上昇抑制剤の製造方
法。 4)水溶性ヘミセルロースに60%エタノール溶液を加
え、そこで生成した沈澱物を分離除去した上澄液からキ
シロース:アラビノースのモル比が1:0.95〜1.
2の糖組成を有する区分を回収することを特徴とする請
求項1記載の血圧降下および上昇抑制剤の製造方法。
[Claims] 1) The molar ratio of xylose:arabinose is 1:0.95
A blood pressure lowering and increasing suppressant comprising water-soluble hemicellulose having a sugar composition of ~1.2. 2) After partially hydrolyzing water-soluble hemicellulose, it is treated with an ultrafiltration membrane to separate and collect a segment having a sugar composition with a xylose:arabinose molar ratio of 1:0.95 to 1.2. The method for producing the agent for lowering and suppressing blood pressure increase according to claim 1. 3) After dissolving the water-soluble hemicellulose in a buffer solution, it was passed through an anion exchange resin to adsorb it, and then passed through an eluent in which the concentration of sodium chloride was gradually increased from 0 mol to 0.4 mol. The molar ratio of xylose:arabinose is 1:0.95, which is eluted with an eluent of .1 to 0.3 mol.
The method for producing a blood pressure lowering and increasing suppressant according to claim 1, characterized in that a fraction having a sugar composition of 1.2 to 1.2 is recovered. 4) A 60% ethanol solution was added to the water-soluble hemicellulose, and the resulting precipitate was separated and removed. From the supernatant, the molar ratio of xylose:arabinose was 1:0.95 to 1.
2. The method for producing a blood pressure lowering and increasing suppressant according to claim 1, wherein a fraction having a sugar composition of 2 is recovered.
JP4940990A 1990-03-02 1990-03-02 Antihypertensive / elevation inhibitor and production method thereof Expired - Lifetime JP2804587B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4940990A JP2804587B2 (en) 1990-03-02 1990-03-02 Antihypertensive / elevation inhibitor and production method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4940990A JP2804587B2 (en) 1990-03-02 1990-03-02 Antihypertensive / elevation inhibitor and production method thereof

Publications (2)

Publication Number Publication Date
JPH03255029A true JPH03255029A (en) 1991-11-13
JP2804587B2 JP2804587B2 (en) 1998-09-30

Family

ID=12830258

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4940990A Expired - Lifetime JP2804587B2 (en) 1990-03-02 1990-03-02 Antihypertensive / elevation inhibitor and production method thereof

Country Status (1)

Country Link
JP (1) JP2804587B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0923382A4 (en) * 1996-08-09 1999-12-22 Mannatech Inc Compositions of plant carbohydrates as dietary supplements
US6929807B1 (en) 1996-08-09 2005-08-16 Mannatech, Inc. Compositions of plant carbohydrates as dietary supplements

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0923382A4 (en) * 1996-08-09 1999-12-22 Mannatech Inc Compositions of plant carbohydrates as dietary supplements
EP1172041A3 (en) * 1996-08-09 2002-08-07 Mannatech, Inc. Compositions of plant carbohydrates as dietary supplements
US6929807B1 (en) 1996-08-09 2005-08-16 Mannatech, Inc. Compositions of plant carbohydrates as dietary supplements
US7157431B2 (en) 1996-08-09 2007-01-02 Mannatech, Inc. Compositions of plant carbohydrates as dietary supplements
US7196064B2 (en) 1996-08-09 2007-03-27 Mannatech, Inc. Compositions of plant carbohydrates as dietary supplements
US7199104B2 (en) 1996-08-09 2007-04-03 Mannatech, Inc. Compositions of plant carbohydrates as dietary supplements
US7202220B2 (en) 1996-08-09 2007-04-10 Mannatech, Inc. Compositions of plant carbohydrates as dietary supplements

Also Published As

Publication number Publication date
JP2804587B2 (en) 1998-09-30

Similar Documents

Publication Publication Date Title
US5332803A (en) Processes for the preparation of amylase inhibitor
US20040023923A1 (en) Cold water soluble beta-glucan product and process for preparing the same
JP2688509B2 (en) Extraction and purification method of hemicellulose
JPH0920672A (en) Antiallergic substance, its production, antiallergic agent and functional food
JPH082270B2 (en) Method for producing dextrin containing dietary fiber
US3152955A (en) Amino acids concentrate
JPH03255029A (en) Inhibitor of rise and drop in blood pressure and its production
JP4473976B2 (en) Blood phosphorus level lowering agent
JPS6236040B2 (en)
JPS6153220A (en) Novel polysaccharide ron substance, its preparation and antitumor agent, immuno-regulating agent and preventive and remedy for infectious disease, containing said substance as active component
JP3007645B2 (en) Inhibitors of intestinal toxic enzymes
JP3155271B2 (en) Yellow containing liquid
JPH04309501A (en) Arabinoxylooligosaccharide
EP0618229B1 (en) Amylase inhibitors
EP0047879B1 (en) Process for preparing modified protein compositions
JP3480965B2 (en) Method for preparing amylase inhibitor
FR2542745A1 (en) POLYSACCHARIDE, ITS PREPARATION AND ITS THERAPEUTIC APPLICATION
EP0637592B1 (en) Processes of producing amylase inhibitors
KR100473445B1 (en) cholesterol reducer and health food containing chitosan and ε-polylysine
KR100729638B1 (en) Anti coagulative Fucosidan isolated from Sporophyll in Undaria pinnatifida and its prepration method
JP2006518190A (en) Method for producing salt containing chitosan having blood pressure lowering function
JP2006254876A (en) Method for producing l-tryptophan
JP2714663B2 (en) Intestinal beneficial bacteria growth promoter
JPH0331181B2 (en)
KR20050071400A (en) Process for preparing water soluble soy oligo-saccharide powder

Legal Events

Date Code Title Description
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090717

Year of fee payment: 11

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090717

Year of fee payment: 11

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100717

Year of fee payment: 12

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100717

Year of fee payment: 12